SPRY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ARS Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky
Notice to pension funds, asset managers, and fiduciaries holding ARS Pharmaceuticals (NASDAQ: SPRY): a securities class action alleges the Company misrepresented the timing of expanded CVS Caremark coverage for neffy before a single-day 23.9% share decline. NEW YORK, Sept. 9, 2026...
Covered in this story
What has happened since
- Ars Pharmaceuticals Inc is down 17.4% since this was published, 43 days ago.
- CVS Health is down 0.9% since this was published, 43 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SPRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ars Pharmaceuticals Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.